Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hybrid PET/MR Imaging to Assess Demyelination and Axonal Injury in Multiple Sclerosis

NCT04521439 is registered in ClinicalTrials.gov with Ruijin Hospital as lead sponsor.

NCT NCT04521439
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04521439 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hybrid PET/MR Imaging to Assess Demyelination and Axonal Injury in Multiple Sclerosis
Lead sponsor
Ruijin Hospital
Phase
Not applicable
Overall status
Completed
Start date
February 1, 2020
Completion date
July 30, 2022
Enrollment
49 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis